Select Page

Managing Osteoporosis; Emphasis on Patients with HIV

Managing Osteoporosis; Emphasis on Patients with HIV

SplashPage_DrBrossard_En

Welcome to the Clinique médicale l’Actuel’s JOURNAL CLUB.
For more than 20 years, the Clinique médicale l’Actuel under the medical direction of Dr. Réjean Thomas, has been bringing together healthcare professionals, with a focus in virology, to learn from guest experts and discuss the most relevant clinical practice challenges facing them today.

[hr]

In this program, Dr. Réjean Thomas sits down with Dr. Jean-Hugues Brossard, endocrinologist, to talk about osteoporosis in the context of HIV.

He discusses how to screen for the disease, the different treatments available and the impact of antiretroviral treatments on the bones.

Publish Date: December 20, 2013
[hr]

This activity is supported by an educational grant from:

[hr]

PROGRAM HIGHLIGHTS

[bullet_list icon=”check” indent=”10px” style=””]

  • Osteoporosis screening
  • Osteoporosis diagnostic tests and investigations
  • Osteoporosis treatments
  • Impact of antiretroviral treatments on the bones[/bullet_list]
  • [hr]

[hr]

FACULTY

[toggle title=”VIEW FACULTY DISCLOSURE / CONFLICT OF INTEREST”]

ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

[hr] Réjean Thomas, MD has a financial interest/relationship or affiliation in the form of: Advisory: AbbVie, Bristol-Myers Squibb Janssen, Gilead, Merck, ViiV Healthcare.

Jean-Hugues Brossard, MD, CSPQ, FRCPC, has a financial interest/relationship or affiliation in the form of: Consultant: Amgen, Eli Lilly, ViiV Healthcare. [hr]

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

[/toggle] [hr]

INTERVIEWER
Réjean Thomas, MD, DHC

CEO | Founder Clinique médicale l’Actuel: Centre of Excellence HIV – STI – Hepatitis Affiliated with the Centre hospitalier de l’Université de Montréal (CHUM) Quebec, Canada

[hr]

INTERVIEWEE
Jean-Hugues Brossard, MD, CSPQ, FRCPC

Endocrinologist Associate Clinical Professor Centre hospitalier de l’Université de Montréal (CHUM) Quebec, Canada            

 

Submit a Comment